42- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2one derivatives as p38 MAPkinase inhibitors for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2005238390 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Ogasawara, Akihito; Nakane, Tetsu; Kubo, Akira; Miyoshi, Hidetaka; Murakami, Takanori; Nakajima, Tatsuo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005238390

PCT Pub. Number WO2005/105790

Priority 60/566,089 29.04.04 US; 2005-007832 14.01.05 JP; 2004-133204 28.04.04 JP

Filing date 28 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 8 January 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105790 Priority application(s): WO2005/105790

8 January 2009 Alteration of Name

  The name of the applicant has been altered to Mitsubishi Tanabe Pharma Corporation Amendments

8 January 2009 Application Accepted

  Published as AU-B-2005238390

11 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Heterocyclic compound

25 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 Feb 2009

2 July 2009 Standard Patent Sealed

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238391-4-amino-5-cyanopyrimidine derivatives

2005238389-Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure